These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2496332)

  • 1. Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits.
    Lyden PD; Zivin JA; Clark WA; Madden K; Sasse KC; Mazzarella VA; Terry RD; Press GA
    Neurology; 1989 May; 39(5):703-8. PubMed ID: 2496332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and angiographic efficacy of tissue plasminogen activator in a cerebral embolization model.
    Phillips DA; Fisher M; Smith TW; Davis MA
    Ann Neurol; 1988 Apr; 23(4):391-4. PubMed ID: 3132892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke.
    Lapchak PA; Araujo DM; Song D; Zivin JA
    Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke.
    Papadopoulos SM; Chandler WF; Salamat MS; Topol EJ; Sackellares JC
    J Neurosurg; 1987 Sep; 67(3):394-8. PubMed ID: 3112328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator.
    Lapchak PA; Araujo DM; Song D; Wei J; Purdy R; Zivin JA
    Stroke; 2002 Jun; 33(6):1665-70. PubMed ID: 12053009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.
    Thomas GR; Thibodeaux H; Errett CJ; Badillo JM; Keyt BA; Refino CJ; Zivin JA; Bennett WF
    Stroke; 1994 Oct; 25(10):2072-8; discussion 2078-9. PubMed ID: 8091454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected].
    Lyden PD; Madden KP; Clark WM; Sasse KC; Zivin JA
    Stroke; 1990 Nov; 21(11):1589-93. PubMed ID: 2122552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Direct continuous observation of in situ thrombolysis in the cerebral embolic model of rabbits].
    Kashiwabara S; Kurokawa Y; Uede T; Hashi K
    No To Shinkei; 1998 Apr; 50(4):347-54. PubMed ID: 9592824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2000 Dec; 31(12):3034-40. PubMed ID: 11108768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].
    Benes V; Zabramski JM; Boston M; Puca A; Spetzler RF
    Stroke; 1990 Nov; 21(11):1594-9. PubMed ID: 2122553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication.
    Nakano T; Irie K; Hayakawa K; Sano K; Nakamura Y; Tanaka M; Yamashita Y; Satho T; Fujioka M; Muroi C; Matsuo K; Ishikura H; Futagami K; Mishima K
    Brain Res; 2015 Oct; 1624():330-335. PubMed ID: 26254727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
    Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K
    Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dodecafluoropentane Emulsion Extends Window for tPA Therapy in a Rabbit Stroke Model.
    Culp WC; Brown AT; Lowery JD; Arthur MC; Roberson PK; Skinner RD
    Mol Neurobiol; 2015 Oct; 52(2):979-84. PubMed ID: 26055229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA.
    Benedict CR; Refino CJ; Keyt BA; Pakala R; Paoni NF; Thomas GR; Bennett WF
    Circulation; 1995 Nov; 92(10):3032-40. PubMed ID: 7586274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits.
    Clark WM; Madden KP; Lyden PD; Zivin JA
    Stroke; 1991 Jul; 22(7):872-6. PubMed ID: 1906646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial.
    Daffertshofer M; Gass A; Ringleb P; Sitzer M; Sliwka U; Els T; Sedlaczek O; Koroshetz WJ; Hennerici MG
    Stroke; 2005 Jul; 36(7):1441-6. PubMed ID: 15947262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator.
    Lapchak PA; Zivin JA
    Stroke; 2003 Aug; 34(8):2013-8. PubMed ID: 12855833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M; Asahi K; Wang X; Lo EH
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-type plasminogen activator improves neurological functions in a rat model of thromboembolic stroke.
    Sakurama T; Kitamura R; Kaneko M
    Stroke; 1994 Feb; 25(2):451-6. PubMed ID: 8303756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of intra-arterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits.
    Hamilton MG; Lee JS; Cummings PJ; Zabramski JM
    Stroke; 1994 Mar; 25(3):651-5; discussion 656. PubMed ID: 8128521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.